Collaborative action of toll-like and nod-like receptors as modulators of the inflammatory response to pathogenic bacteria

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Oviedo Boyso, Javier ^a   Bravo Patiño, Alejandro ^a   Baizabal Aguirre, Víctor M ^a  

^a UNIVERSIDAD MICHOACANA DE SAN NICOLÁS DE HIDALGO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; CYTOKINE; GLYCOSYLPHOSPHATIDYLINOSITOL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERFERON REGULATORY FACTOR; LIGAND; LIPOARABINOMANNAN; LIPOPEPTIDE; LIPOPOLYSACCHARIDE; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR AP 1; ANTIMICROBIAL CATIONIC PEPTIDE; LECTIN; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN PROTEIN; PATTERN RECOGNITION RECEPTOR;

BACTERIAL CLEARANCE; BACTERIUM; BONE MARROW CELL; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; INTESTINE FLORA; MACROPHAGE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PHAGOCYTE; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION; ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IMMUNOLOGY; METABOLISM; PATHOGENICITY; PATHOPHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; SEPSIS;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; LECTINS; LIGANDS; MODELS, BIOLOGICAL; NOD SIGNALING ADAPTOR PROTEINS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, PATTERN RECOGNITION; SEPSIS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84918814358     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/432785     Document Type: Review

References (193)

1. H. Kumar, T. Kawai, and S. Akira, "Pathogen recognition in the innate immune response," Biochemical Journal, vol. 420, no. 1, pp. 1-16, 2009.
2. J. S. Ayres and D. S. Schneider, "Tolerance of infections," Annual Review of Immunology, vol. 30, pp. 271-294, 2012.
3. H. Kumar, T. Kawai, and S. Akira, "Toll-like receptors and innate immunity," Biochemical and Biophysical Research Communications, vol. 388, no. 4, pp. 621-625, 2009.
4. S. Kumar, H. Ingle, D. V. R. Prasad, and H. Kumar, "Recognition of bacterial infection by innate immune sensors," Critical Reviews in Microbiology, vol. 39, no. 3, pp. 229-246, 2013.
5. O. Takeuchi, T. Kawai, P. F. Mühlradt et al., "Discrimination of bacterial lipoproteins by Toll-like recepttor 6," International Immunology, vol. 13, no. 7, pp. 933-940, 2001.
6. U. Zähringer, B. Lindner, S. Inamura, H. Heine, and C. Alexander, "TLR2 - promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity," Immunobiology, vol. 213, no. 3-4, pp. 205-224, 2008.
7. S. Krishna, A. Ray, S. K. Dubey et al., "Lipoglycans contribute to innate immune detection of mycobacteria," PLoS ONE, vol. 6, no. 12, Article ID e28476, 2011.
8. L. Blanc, R. Castanier, A. K. Mishra et al., "Gram-positive bacterial lipoglycans based on a glycosylated diacylglycerol lipid anchor are microbe-associated molecular patterns recognized by TLR2," PLoS ONE, vol. 8, no. 11, Article ID e81593, 2013.
9. S. Akira, S. Uematsu, and O. Takeuchi, "Pathogen recognition and innate immunity," Cell, vol. 124, no. 4, pp. 783-801, 2006.
10. R. Medzhitov, "TLR-mediated innate immune recognition," Seminars in Immunology, vol. 19, no. 1, pp. 1-2, 2007.
11. T. Kawai and S. Akira, "The role of pattern-recognition receptors in innate immunity: update on toll-like receptors," Nature Immunology, vol. 11, no. 5, pp. 373-384, 2010.
12. M. A. Anwar, S. Basith, and S. Choi, "Negative regulatory approaches to the attenuation of Toll-like receptor signaling," Experimental and Molecular Medicine, vol. 45, pp. 1-14, 2013.
13. T. Langefeld, M. Walid, R. Ghai, and T. Chakraborty, "Toll-like receptors and NOD-like receptors: domain architecture and cellular signalling," Advances in Experimental Medicine and Biology, vol. 653, pp. 48-57, 2009.
14. C. Richez, P. Blanco, I. Rifkin, J.-F. Moreau, and T. Schaeverbeke, "Role for toll-like receptors in autoimmune disease: the example of systemic lupus erythematosus," Joint Bone Spine, vol. 78, no. 2, pp. 124-130, 2011.
15. Y. Xi, F. Shao, X. Y. Bai, G. Cai, Y. Lv, and X. Chen, "Changes in the expression of the Toll-like receptor system in the aging rat kidneys," PLoS One, vol. 9, no. 5, Article ID e96351, 2014.
16. X. He, Z. Jing, and G. Cheng, "MicroRNAs: new regulators of toll-like receptor signalling pathways," BioMed Research International, vol. 2014, Article ID 945169, 14 pages, 2014.
17. A. R. Jayakumar, X. Y. Tong, K.M. Curtis, R. Ruiz-Cordero, M. T. Abreu, and M. D. Norenberg, "Increased Toll-like receptor 4 in cerebral endothelial cell contributes to the astrocyte swelling and brain edema in acute hepatic encephalopathy," Journal of Neurochemistry, vol. 128, no. 6, pp. 890-903, 2014.
18. A. Klonowska-Szymczyk, A. Wolska, T. Robak, B. Cebula-Obrzut, P. Smolewski, and E. Robak, "Expression of toll-like receptors 3, 7, and 9 in peripheral blood mononuclear cells from patients with systemic lupus erythematosus," Mediators of Inflammation, vol. 2014, Article ID 381418, 11 pages, 2014.
19. L. A. J. O'Neill, E. J. Hennessy, A. E. Parker, and L. A. J. O'Neill, "Targeting toll-like receptors: emerging therapeutics?" Nature Reviews Drug Discovery, vol. 9, no. 4, pp. 293-307, 2010.
20. M. T. Abreu, "Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function," Nature Reviews Immunology, vol. 10, no. 2, pp. 131-144, 2010.
21. I. Ioannidis, F. Ye, B. McNally, M. Willette, and E. Flaño, "Toll-like receptor expression and induction of type I and type III interferons in primary airway epithelial cells," Journal of Virology, vol. 87, no. 6, pp. 3261-3270, 2013.
22. M. Pasparakis, I. Haase, and F. O. Nestle, "Mechanisms regulating skin immunity and inflammation," Nature Reviews Immunology, vol. 14, no. 5, pp. 289-301, 2014.
23. M. J. Mulla, K. Myrtolli, S. Tadesse et al., "Cutting-edge report: TLR10 plays a role in mediating bacterial peptidoglycan-induced trophoblast apoptosis," The American Journal of Reproductive Immunology, vol. 69, no. 5, pp. 449-453, 2013.
24. T. Regan, K. Nally, R. Carmody et al., "Identification of TLR10 as a key mediator of the inflammatory response to Listeria monocytogenes in intestinal epithelial cells and macrophages," The Journal of Immunology, vol. 191, no. 12, pp. 6084-6092, 2013.
25. S. M. Y. Lee, K.-H. Kok, M. Jaume et al., "Toll-like receptor 10 is involved in induction of innate immune responses to influenza virus infection," Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 10, pp. 3793-3798, 2014.
26. W. A. Andrade, M. D. C. Souza, E. Ramos-Martinez et al., "Combined action of nucleic acid-sensing toll-like receptors and TLR11/TLR12 heterodimers imparts resistance to toxoplasma gondii in mice," Cell Host andMicrobe, vol. 13, no. 1, pp. 42-53, 2013.
27. J. C. Roach, G. Glusman, L. Rowen et al., "The evolution of vertebrate Toll-like receptors," Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 27, pp. 9577-9582, 2005.
28. E. Cario and D. K. Podolsky, "Differential alteration in intestinal epithelial cell expression of Toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease," Infection and Immunity, vol. 68, no. 12, pp. 7010-7017, 2000.
29. A. T. Gewirtz, T. A. Navas, S. Lyons, P. J. Godowski, and J. L. Madara, "Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression," TheJournal of Immunology, vol. 167, no. 4, pp. 1882-1885, 2001.
30. J. M. Otte, E. Cario, and D. K. Podolsky, "Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells," Gastroenterology, vol. 126, no. 4, pp. 1054-1070, 2004.
31. L. Shang, M. Fukata, N. Thirunarayanan et al., "TLR signaling in small intestinal epithelium promotes B cells recruitment and IgA production in lamina propria," Gastroenterology, vol. 135, no. 2, pp. 529-538, 2008.
32. E.C. Lavelle, C. Murphy, L. A. J. O'Neill, and E.M. Creagh, "The role of TLRs, NLRs, and RLRs inmucosal innate immunity and homeostasis," Mucosal Immunology, vol. 3, no. 1,pp. 17-28, 2010.
33. Q. Sha, A. Q. Truong-Tran, J. R. Plitt, L. A. Beck, and R. P. Schleimer, "Activation of airway epithelial cells by toll-like receptor agonists," The American Journal of Respiratory Cell and Molecular Biology, vol. 31, no. 3, pp. 358-364, 2004.
34. A. K. Mayer, M. Muehmer, J. Mages et al., "Differential recognition of TLR-dependent microbial ligands in human bronchial epithelial cells," The Journal of Immunology, vol. 178, no. 5, pp. 3134-3142, 2007.
35. J. L. Koff, M. X. G. Shao, I. F. Ueki, and J. A. Nadel, "Multiple TLRs activate EGFR via a signaling cascade to produce innate immune responses in airway epithelium," American Journal of Physiology: Lung Cellular and Molecular Physiology, vol. 294, no. 6, pp. L1068-L1075, 2008.
36. L. Guillott, S. Medjane, K. Le-Barillec et al., "Response of human pulmonary epithelial cells to lipopolysaccharide involves toll-like receptor 4 (TLR4)-dependent signaling pathways: evidence for an intracellular compartmentalization of TLR4," Journal of Biological Chemistry, vol. 279, no. 4, pp. 2712-2718, 2004.
37. D. Schneberger, S. Caldwell, R. Kanthan, and B. Singh, "Expression of Toll-like receptor 9 in mouse and human lungs," Journal of Anatomy, vol. 222, no. 5, pp. 495-503, 2013.
38. N. Iram, M. Mildner, M. Prior et al., "Age-related changes in expression and function of toll-like receptors in human skin," Development, vol. 139, no. 22, pp. 4210-4219, 2012.
39. B. S. Baker, J. M. Ovigne, A. V. Powles, S. Corcoran, and L. Fry, "Normal keratinocytes express Toll-like receptors (TLRs) 1, 2 and 5: modulation of TLR expression in chronic plaque psoriasis," British Journal of Dermatology, vol. 148, no. 4, pp. 670-679, 2003.
40. A. Pivarcsi, L. Bodai, B. Réthi et al., "Expression and function of Toll-like receptors 2 and 4 in human keratinocytes," International Immunology, vol. 15, no. 6, pp. 721-730, 2003.
41. G. Köllisch, B. N. Kalali, V. Voelcker et al., "Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes," Immunology, vol. 114, no. 4, pp. 531-541, 2005.
42. X. Dai, K. Sayama, K. Yamasaki et al., "SOCS1-negative feedback of STAT1 activation is a key pathway in the dsRNA-induced innate immune response of human keratinocytes," Journal of Investigative Dermatology, vol. 126, no. 7, pp. 1574-1581, 2006.
43. B. N. Kalali, G. Köllisch, J. Mages et al., "Double-stranded RNA induces an antiviral defense status in epidermal keratinocytes through TLR3-, PKR-, and MDA5/RIG-I-mediated differential signaling," The Journal of Immunology, vol. 181, no. 4, pp. 2694-2704, 2008.
44. M. C. Lebre, A. M. G. Van Der Aar, L. Van Baarsen et al., "Human keratinocytes express functional toll-like receptor 3, 4, 5, and 9," Journal of Investigative Dermatology, vol. 127, no. 2, pp. 331-341, 2007.
45. L. S. Miller and R. L. Modlin, "Human keratinocyte Toll-like receptors promote distinct immune responses," Journal of Investigative Dermatology, vol. 127, no. 2, pp. 262-263, 2007.
46. J. P.-Y. Ting, R.C. Lovering, E. S. Alnemri et al., "The NLR gene family: a standard nomenclature," Immunity, vol. 28, no. 3, pp. 285-287, 2008.
47. L. Franchi, J. H. Park, M. H. Shaw et al., "Intracellular NOD-like receptors in innate immunity, infection and disease," Cellular Microbiology, vol. 10, no. 1, pp. 1-8, 2008.
48. I. C. Allen, M. A. Scull, C. B. Moore et al., "The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA," Immunity, vol. 30, no. 4, pp. 556-565, 2009.
49. A. M. Kvarnhammar, L. Tengroth, M. Adner, and L.-O. Cardell, "Innate immune receptors in human airway smooth muscle cells: activation by TLR1/2, TLR3, TLR4, TLR7 and NOD1 agonists," PLoS ONE, vol. 8, no. 7, Article ID e68701, 2013.
50. N. Inohara, M. Chamaillard, C. McDonald, and G. Nuñez, "NOD-LRR proteins: role in host-microbial interactions and inflammatory disease," Annual Review of Biochemistry, vol. 74, pp. 355-383, 2005.
51. J. H. Fritz, R. L. Ferrero, D. J. Philpott, and S. E. Girardin, "Nod-like proteins in immunity, inflammation and disease," Nature Immunology, vol. 7, no. 12, pp. 1250-1257, 2006.
52. E. M. Creagh and L. A. J. O'Neill, "TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity," Trends in Immunology, vol. 27, no. 8, pp. 352-357, 2006.
53. A. Uehara, Y. Fujimoto, K. Fukase, and H. Takada, "Various human epithelial cells express functional Toll-like receptors, NOD1 and NOD2 to produce anti-microbial peptides, but not proinflammatory cytokines," Molecular Immunology, vol. 44, no. 12, pp. 3100-3111, 2007.
54. L. Le Bourhis, S. Benko, and S. E. Girardin, "Nod1 and Nod2 in innate immunity and human inflammatory disorders," Biochemical Society Transactions, vol. 35, no. 6, pp. 1479-1484, 2007.
55. D. J. Philpott, S. Yamaoka, A. Israël, and P. J. Sansonetti, "Invasive Shigella flexneri activates NF-κB through a lipopolysaccharide-dependent innate intracellular response and leads to IL-8 expression in epithelial cells," Journal of Immunology, vol. 165, no. 2, pp. 903-914, 2000.
56. S. E. Girardin, R. Tournebize, M. Mavris et al., "CARD4/Nod1 mediates NF-κB and JNK activation by invasive Shigella flexneri," EMBO Reports, vol. 2, no. 8, pp. 736-742, 2001.
57. J. G. Kim, S. J. Lee, and M. F. Kagnoff, "Nod1 is an essential signal transducer in intestinal epithelial cells infected with bacteria that avoid recognition by Toll-like receptors," Infection and Immunity, vol. 72, no. 3, pp. 1487-1495, 2004.
58. B. Opitz, S. Förster, A. C. Hocke et al., "Nod1-mediated endothelial cell activation by Chlamydophila pneumoniae," Circulation Research, vol. 96, no. 3, pp. 319-326, 2005.
59. L. Welter-Stahl, D. M. Ojcius, J. Viala et al., "Stimulation of the cytosolic receptor for peptidoglycan, Nod1, by infection with Chlamydia trachomatis or Chlamydia muridarum," Cellular Microbiology, vol. 8, no. 6, pp. 1047-1057, 2006.
60. M. Kaparakis, L. Turnbull, L. Carneiro et al., "Bacterial membrane vesicles deliver peptidoglycan to NOD1 in epithelial cells," Cellular Microbiology, vol. 12, no. 3, pp. 372-385, 2010.
61. T. A. Kufer, D. J. Banks, and D. J. Philpott, "Innate immune sensing of microbes by Nod proteins," Annals of the New York Academy of Sciences, vol. 1072, pp. 19-27, 2006.
62. S. J. Robertson and S. E. Girardin, "Nod-like receptors in intestinal host defense: controlling pathogens, the microbiota, or both?" Current Opinion in Gastroenterology, vol. 29, no. 1, pp. 15-22, 2013.
63. S. E. Girardin, I. G. Boneca, J. Viala et al., "Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection," Journal of Biological Chemistry, vol. 278, no. 11, pp. 8869-8872, 2003.
64. H.N. Qiu, C. K. Wong, I. M. T. Chu, S. Hu, and C. W. K. Lam, "Muramyl dipeptide mediated activation of human bronchial epithelial cells interacting with basophils: a novel mechanism of airway inflammation," Clinical and Experimental Immunology, vol. 172, no. 1, pp. 81-94, 2013.
65. M. Leissinger, R. Kulkarni, R. L. Zemans, G. P. Downey, and S. Jeyaseelan, "Investigating the role of NOD-like receptors in bacterial lung infection," The American Journal of Respiratory Critical Care Medicine, 2014.
66. H. Slevogt, J. Seybold, K. N. Tiwari et al., "Moraxella catarrhalis is internalized in respiratory epithelial cells by a trigger-like mechanism and initiates a TLR2- and partly NOD1-dependent inflammatory immune response," Cellular Microbiology, vol. 9, no. 3, pp. 694-707, 2007.
67. B. Opitz, A. Püschel, W. Beermann et al., "Listeria monocytogenes activated p38 MAPK and induced IL-8 secretion in a nucleotide-binding oligomerization domain 1-dependent manner in endothelial cells," The Journal of Immunology, vol. 176, no. 1, pp. 484-490, 2006.
68. J. L. Barton, T. Berg, L. Didon, and M. Nord, "The pattern recognition receptor Nod1 activates CCAAT/enhancer binding protein β signalling in lung epithelial cells," European Respiratory Journal, vol. 30, no. 2, pp. 214-222, 2007.
69. A. Ma˚nsson Kvarnhammar, L. Tengroth, M. Adner, and L. O. Cardell, "Innate immune receptors in human airway smooth muscle cells: activation by TLR1/2 TLR3, TLR4, TLR7 andNOD agonists," PLoS ONE, vol. 8, no. 7, Article ID e68701, 2013.
70. K. Shimada, S. Chen, P. W. Dempsey et al., "The NOD/RIP2 pathway is essential for host defenses against Chlamydophila pneumoniae lung infection," PLoS Pathogens, vol. 5, no. 4, Article ID e1000379, 2009.
71. V. Regueiro, D. Moranta, C. G. Frank et al., "Klebsiella pneumoniae subverts the activation of inflammatory responses in a NOD1-dependent manner," Cellular Microbiology, vol. 13, no. 1, pp. 135-153, 2011.
72. W. R. Berrington, R. Iyer, R. D. Wells, K. D. Smith, S. J. Skerrett, and T. R. Hawn, "NOD1 and NOD2 regulation of pulmonary innate immunity to Legionella pneumophila," European Journal of Immunology, vol. 40, no. 12, pp. 3519-3527, 2010.
73. L. H. Travassos, L. A. M. Carneiro, S. E. Girardin et al., "Nod1 participates in the innate immune response to Pseudomonas aeruginosa," The Journal of Biological Chemistry, vol. 280, no. 44, pp. 36714-36718, 2005.
74. Y.-G. Kim, J.-H. Park, S. Daignault, K. Fukase, and G. Núñez, "Cross-tolerization between Nod1 and Nod2 signaling results in reduced refractoriness to bacterial infection in Nod2-deficient macrophages," Journal of Immunology, vol. 181, no. 6, pp. 4340-4346, 2008.
75. B. Opitz, A. Püschel, B. Schmeck et al., "Nucleotide-binding oligomerization domain proteins are innate immune receptors for internalized Streptococcus pneumoniae," Journal of Biological Chemistry, vol. 279, no. 35, pp. 36426-36432, 2004.
76. B. Theivanthiran, S. Batra, G. Balamayooran et al., "NOD2 signaling contributes to host defense in the lungs against Escherichia coli infection," Infection and Immunity, vol. 80, no. 7, pp. 2558-2569, 2012.
77. G. Ferwerda, S. E. Girardin, B.-J. Kullberg et al., "NOD2 and toll-like receptors are nonredundant recognition systems of Mycobacterium tuberculosis," PLoS Pathogens, vol. 1, no. 3, article e34, 2005.
78. K. M. Davis, S. Nakamura, and J. N. Weiser, "Nod2 sensing of lysozyme-digested peptidoglycan promotes macrophage recruitment and clearance of S. pneumoniae colonization in mice," The Journal of Clinical Investigation, vol. 121, no. 9, pp. 3666-3676, 2011.
79. R. Kapetanovic, G. Jouvion, C. Fitting et al., "Contribution of NOD2 to lung inflammation during Staphylococcus aureus-induced pneumonia," Microbes and Infection, vol. 12, no. 10, pp. 759-767, 2010.
80. C. Chaput, L. E. Sander, N. Suttorp, and B. Opitz, "NOD-like receptors in lung diseases," Frontiers in Immunology, vol. 4, article 393, 2013.
81. F. Bauernfeind and V. Hornung, "Of inflammasomes and pathogens - sensing of microbes by the inflammasome," EMBO Molecular Medicine, vol. 5, no. 6, pp. 814-826, 2013.
82. J. A. Hirota, S. A. Hirota, S. M. Warner et al., "The airway epithelium nucleotide-binding domain and leucine-rich repeat protein 3 inflammasome is activated by urban particulate matter," Journal of Allergy and Clinical Immunology, vol. 129, no. 4, pp. 1116.e6-1125.e6, 2012.
83. E. S. Alnemri, "Sensing cytoplasmic danger signals by the inflammasome," Journal of Clinical Immunology, vol. 30, no. 4, pp. 512-519, 2010.
84. S. Kim, F. Bauernfeind, A. Ablasser et al., "Listeria monocytogenes is sensed by the NLRP3 and AIM2 inflammasome," European Journal of Immunology, vol. 40, no. 6, pp. 1545-1551, 2010.
85. K. Meixenberger, F. Pache, J. Eitel et al., "Listeria monocytogenes-infected human peripheral blood mononuclear cells produce IL-1β, depending on listeriolysin O and NLRP3," Journal of Immunology, vol. 184, no. 2, pp. 922-930, 2010.
86. R. Muñoz-Planillo, L. Franchi, L. S. Miller, and G. Núñez, "A critical role for hemolysins and bacterial lipoproteins in Staphylococcus aureus-induced activation of the Nlrp3 inflammasome," The Journal of Immunology, vol. 183, no. 6, pp. 3942-3948, 2009.
87. J. Eitel, K. Meixenberger, C. van Laak et al., "Rac1 regulates theNLRP3 inflammasome which mediates IL-1beta production in Chlamydophila pneumoniae infected human mononuclear cells," PLoS ONE, vol. 7, no. 1, Article ID e30379, 2012.
88. F. Carlsson, J. Kim, C. Dumitru et al., "Host-detrimental role of Esx-1-mediated inflammasome activation in Mycobacterial infection," PLoS Pathogens, vol. 6, no. 5, pp. 1-12, 2010.
89. C. L. Case, L. J. Kohler, J. B. Lima et al., "Caspase-11 stimulates rapid flagellin-independent pyroptosis in response to Legionella pneumophila," Proceedings of the National Academy of Sciences of theUnited States of America, vol. 110, no. 5, pp. 1851-1856, 2013.
90. I. C. Allen, M. A. Scull, C. B. Moore et al., "The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA," Immunity, vol. 30, no. 4, pp. 556-565, 2009.
91. J. Pothlichet, I. Meunier, B. K. Davis et al., "Type I IFN triggers RIG-I/TLR3/NLRP3-dependent inflammasome activation in influenza A virus infected cells," PLoS Pathogens, vol. 9, no. 4, Article ID e1003256, 2013.
92. E. Park, H. S. Na, Y.-R. Song, S. Y. Shin, Y.-M. Kim, and J. Chung, "Activation of NLRP3 and AIM2 inflammasomes by Porphyromonas gingivalis infection," Infection and Immunity, vol. 82, no. 1, pp. 112-123, 2014.
93. N. Saïd-Sadier, E. Padilla, G. Langsley, and D. M. Ojcius, "Aspergillus fumigatus stimulates the NLRP3 inflammasome through a pathway requiring ROS production and the syk tyrosine kinase," PLoS ONE, vol. 5, no. 4, Article ID e10008, 2010.
94. A. J. McCoy, Y. Koizumi, N. Higa, and T. Suzuki, "Differential regulation of caspase-1 activation via NLRP3/NLRC4 inflammasomes mediated by aerolysin and type III secretion system during Aeromonas veronii infection," The Journal of Immunology, vol. 185, no. 11, pp. 7077-7084, 2010.
95. F. Martinon, K. Burns, and J. Tschopp, "The Inflammasome: A molecular platform triggering activation of inflammatory caspases and processing of proIL-β," Molecular Cell, vol. 10, no. 2, pp. 417-426, 2002.
96. J. A. Kummer, R. Broekhuizen, H. Everett et al., "Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response," Journal of Histochemistry and Cytochemistry, vol. 55, no. 5, pp. 443-452, 2007.
97. E. D. Boyden and W. F. Dietrich, "Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin," Nature Genetics, vol. 38, no. 2, pp. 240-244, 2006.
98. S. E. Ewald, J. Chavarria-Smith, and J. C. Boothroyd, "NLRP1 is an inflammasome sensor for Toxoplasma gondii," Infection and Immunity, vol. 82, no. 1, pp. 460-468, 2014.
99. A. D. Radian, L. de Almeida, A. Dorfleutner, and C. Stehlik, "NLRP7 and related inflammasome activating pattern recognition receptors and their function in host defense and disease," Microbes and Infection, vol. 15, no. 8-9, pp. 630-639, 2013.
100. S. Khare, A. Dorfleutner, N. B. Bryan et al., "An NLRP7-containing inflammasome mediates recognition of microbial lipopeptides in human macrophages," Immunity, vol. 36, no. 3, pp. 464-476, 2012.
101. J. Cui, Y. Li, L. Zhu et al., "NLRP4 negatively regulates type I interferon signaling by targeting the kinase TBK1 for degradation via the ubiquitin ligase DTX4," Nature Immunology, vol. 13, no. 4, pp. 387-395, 2012.
102. L. Fiorentino, C. Stehlik, V. Oliveira, M. E. Ariza, A. Godzik, and J. C. Reed, "A novel PAAD-containing protein that modulates NF-κB induction by cytokines tumor necrosis factor-α and interleukin-1β," The Journal of Biological Chemistry, vol. 277, no. 38, pp. 35333-35340, 2002.
103. N. Jounai, K. Kobiyama, M. Shiina, K. Ogata, K. J. Ishii, and F. Takeshita, "NLRP4 negatively regulates autophagic processes through an association with Beclin1," The Journal of Immunology, vol. 186, no. 3, pp. 1646-1655, 2011.
104. P. K. Anand, R. K. S. Malireddi, J. R. Lukens et al., "NLRP6 negatively regulates innate immunity and host defence against bacterial pathogens," Nature, vol. 488, no. 7411, pp. 389-393, 2012.
105. P. K. Anand and T.-D. Kanneganti, "NLRP6 in infection and inflammation," Microbes and Infection, vol. 15, no. 10-11, pp. 661-668, 2013.
106. J. C. Arthur, J. D. Lich, Z. Ye et al., "NLRP12 controls dendritic and myeloid cell migration to affect contact hypersensitivity," Journal of Immunology, vol. 185, no. 8, pp. 4515-4519, 2010.
107. C. A. Lord, D. Savitsky, R. Sitcheran et al., "Blimp-1/PRDM1 mediates transcriptional suppression of the NLR gene NLRP12/monarch-1," The Journal of Immunology, vol. 182, no. 5, pp. 2948-2958, 2009.
108. I. C. Allen, E. McElvania-TeKippe, J. E. Wilson et al., "Characterization of NLRP12 during the in vivo host immune response to Klebsiella pneumoniae and mycobacterium tuberculosis," PLoS ONE, vol. 8, no. 4, Article ID e60842, 2013.
109. E. A. Miao, C. M. Alpuche-Aranda, M. Dors et al., "Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1β via Ipaf," Nature Immunology, vol. 7, no. 6, pp. 569-575, 2006.
110. M. Lamkanfi and V. M. Dixit, "Inflammasomes: guardians of cytosolic sanctity," Immunological Reviews, vol. 227, no. 1, pp. 95-105, 2009.
111. L. Franchi, R. Muñoz-Planillo, and G. Núñez, "Sensing and reacting to microbes through the inflammasomes," Nature Immunology, vol. 13, no. 4, pp. 325-332, 2012.
112. T. Suzuki, L. Franchi, C. Toma et al., "Differential regulation of caspase-1 activation, pyroptosis, and autophagy via Ipaf and ASC in Shigella-infected macrophages," PLoS pathogens, vol. 3, no. 8, article e111, 2007.
113. E. A. Miao, D. P. Mao, N. Yudkovsky et al., "Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome," Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 7, pp. 3076-3080, 2010.
114. E. A. Miao and S. E. Warren, "Innate immune detection of bacterial virulence factors via the NLRC4 inflammasome," Journal of Clinical Immunology, vol. 30, no. 4, pp. 502-506, 2010.
115. F. A. Carvalho, I. Nalbantoglu, J. D. Aitken et al., "Cytosolic flagellin receptor NLRC4 protects mice against mucosal and systemic challenges," Mucosal Immunology, vol. 5, no. 3, pp. 288-298, 2012.
116. K. Schroder and J. Tschopp, "The inflammasomes," Cell, vol. 140, no. 6, pp. 821-832, 2010.
117. V. A. K. Rathinam, Z. Jiang, S. N. Waggoner et al., "The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses," Nature Immunology, vol. 11, no. 5, pp. 395-402, 2010.
118. R. J. Dotson, S. M. Rabadi, E. L. Westcott et al., "Repression of inflammasome by Francisella tularensis during early stages of infection," Journal of Biological Chemistry, vol. 288, no. 33, pp. 23844-23857, 2013.
119. K. Belhocine and D. M. Monack, "Francisella infection triggers activation of the AIM2 inflammasome in murine dendritic cells," Cellular Microbiology, vol. 14, no. 1, pp. 71-80, 2012.
120. K. Tsuchiya, H. Hara, I. Kawamura et al., "Involvement of absent in melanoma 2 in inflammasome activation in macrophages infected with Listeria monocytogenes," Journal of Immunology, vol. 185, no. 2, pp. 1186-1195, 2010.
121. S. E. Warren, A. Armstrong, M. K. Hamilton et al., "cutting edge: Cytosolic bacterial DNA activates the inflammasome via Aim2," Journal of Immunology, vol. 185, no. 2, pp. 118-121, 2010.
122. J. Wu, T. Fernandes-Alnemri, and E. S. Alnemri, "Involvement of the AIM2, NLRC4, and NLRP3 inflammasomes in caspase-1 activation by Listeria monocytogenes," Journal of Clinical Immunology, vol. 30, no. 5, pp. 693-702, 2010.
123. H. Saiga, S. Kitada, Y. Shimada et al., "Critical role of AIM2 in Mycobacterium tuberculosis infection," International Immunology, vol. 24, no. 10, pp. 637-644, 2012.
124. Y. Yang, X. Zhou, M. Kouadir et al., "The AIM2 inflammasome is involved in macrophage activation during infection with virulent Mycobacterium bovis strain," The Journal of Infectious Diseases, vol. 208, no. 11, pp. 1849-1858, 2013.
125. R. Fang, H. Hara, S. Sakai et al., "Type I interferon signaling regulates activation of the absent in melanoma 2 inflammasome during Streptococcus pneumoniae Infection," Infection and Immunity, vol. 82, no. 6, pp. 2310-2317, 2014.
126. R. Hanamsagar, A. Aldrich, and T. Kielian, "Critical role for theAIM2 inflammasome during acute CNS bacterial infection," Journal of Neurochemistry, vol. 129, no. 4, pp. 704-711, 2014.
127. M. C. Chambers and D. S. Schneider, "Balancing resistance and infection tolerance through metabolic means," Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 35, pp. 13886-13887, 2012.
128. R. G. Baker, M. S. Hayden, and S. Ghosh, "NF-κB, inflammation, and metabolic disease," Cell Metabolism, vol. 13, no. 1, pp. 11-22, 2011.
129. M. S. Hayden, A. P. West, and S. Ghosh, "NF-κB and the immune response," Oncogene, vol. 25, no. 51, pp. 6758-6780, 2006.
130. M. S. Hayden and S. Ghosh, "Shared principles in NF- B signaling," Cell, vol. 132, no. 3, pp. 344-362, 2008.
131. S. Akira and K. Takeda, "Toll-like receptor signalling," Nature Reviews Immunology, vol. 4, no. 7, pp. 499-511, 2004.
132. T. Kawai and S. Akira, "TLR signaling," Cell Death and Differentiation, vol. 13, no. 5, pp. 816-825, 2006.
133. A. Roeder, C. J. Kirschning, R. A. Rupec, M. Schaller, G. Weindl, and H. C. Korting, "Toll-like receptors as key mediators in innate antifungal immunity," Medical Mycology, vol. 42, no. 6, pp. 485-498, 2004.
134. A. A. Koblansky, D. Jankovic, H. Oh et al., "Recognition of profilin by Toll-like receptor 12 is critical for host resistance to Toxoplasma gondii," Immunity, vol. 38, no. 1, pp. 119-130, 2013.
135. K. Takeda and S. Akira, "Toll-like receptors in innate immunity," International Immunology, vol. 17, no. 1, pp. 1-14, 2005.
136. C. A. Janeway Jr. and R. Medzhitov, "Innate immune recognition," Annual Review of Immunology, vol. 20, pp. 197-216, 2002.
137. M. S. Hayden and S. Ghosh, "NF-κB, the first quarter-century: remarkable progress and outstanding questions," Genes and Development, vol. 26, no. 3, pp. 203-234, 2012.
138. T. Kawai and S. Akira, "Toll-like receptor downstream signaling," Arthritis Research and Therapy, vol. 7, no. 1, pp. 12-19, 2005.
139. E. Meylan, K. Burns, K. Hofmann et al., "RIP1 is an essential mediator of Toll-like receptor 3-induced NF-κB activation," Nature Immunology, vol. 5, no. 5, pp. 503-507, 2004.
140. G. Oganesyan, S. K. Saha, B. Guo et al., "Critical role of TRAF3 in the toll-like receptor-dependent and -independent antiviral response," Nature, vol. 439, no. 7073, pp. 208-211, 2006.
141. T.-L. Chau, R. Gioia, J.-S. Gatot et al., "Are the IKKs and IKK-related kinases TBK1 and IKK-ε similarly activated?" Trends in Biochemical Sciences, vol. 33, no. 4, pp. 171-180, 2008.
142. M. A. Ermolaeva, M.-C. Michallet, N. Papadopoulou et al., "Function of TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent inflammatory responses," Nature Immunology, vol. 9, no. 9, pp. 1037-1046, 2008.
143. K. Honda, H. Yanai, H. Negishi et al., "IRF-7 is the master regulator of type-I interferon-dependent immune responses," Nature, vol. 434, no. 7034, pp. 772-777, 2005.
144. B. Barnes, B. Lubyova, and P. M. Pitha, "On the role of IRF in host defense," Journal of Interferon and Cytokine Research, vol. 22, no. 1, pp. 59-71, 2002.
145. C. M. Cham, K. Ko, and T. B. Niewold, "Interferon regulatory factor 5 in the pathogenesis of systemic lupus erythematosus," Clinical and Developmental Immunology, vol. 2012, Article ID 780436, 11 pages, 2012.
146. C. Bourgeois, O. Majer, I. E. Frohner et al., "Conventional dendritic cellsmount a type I IFN response against Candida spp. requiring novel phagosomal TLR7-mediated IFN-β signaling," The Journal of Immunology, vol. 186, no. 5, pp. 3104-3112, 2011.
147. C. Biondo, A. Malara, A. Costa et al., "Recognition of fungal RNA by TLR7 has a nonredundant role in host defense against experimental candidiasis," European Journal of Immunology, vol. 42, no. 10, pp. 2632-2643, 2012.
148. S. E. Girardin, I. G. Boneca, J. Viala et al., "Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection," The Journal of Biological Chemistry, vol. 278, no. 11, pp. 8869-8872, 2003.
149. C.-C. Kuo, A. Lee, and L. A. Campbell, "Cleavage of the N-linked oligosaccharide from the surfaces of Chlamydia species affects attachment and infectivity of the organisms in human epithelial and endothelial cells," Infection and Immunity, vol. 72, no. 11, pp. 6699-6701, 2004.
150. B. Fournier and D. J. Philpott, "Recognition of Staphylococcus aureus by the innate immune system," Clinical Microbiology Reviews, vol. 18, no. 3, pp. 521-540, 2005.
151. L. L. Bourhis, S. Benko, and S. E. Girardin, "Nod1 and Nod2 in innate immunity and human inflammatory disorders," Biochemical Society Transactions, vol. 35, no. 6, pp. 1479-1484, 2007.
152. X. Xie, L. Wang, F. Gong et al., "Intracellular Staphylococcus aureus-induced NF-κB activation and proinflammatory responses of P815 cells are mediated by NOD2," Journal of Huazhong University of Science and Technology (Medical Sciences), vol. 32, no. 3, pp. 317-323, 2012.
153. C. Chaput, L. E. Sander, N. Suttorp, and B. Opitz, "NOD-like receptors in lung diseases," Frontiers in Immunology, vol. 4, no. 393, pp. 1-12, 2013.
154. K. Kersse, M. J. M. Bertrand, M. Lamkanfi, and P. Vandenabeele, "NOD-like receptors and the innate immune system: coping with danger, damage and death," Cytokine & Growth Factor Reviews, vol. 22, no. 5-6, pp. 257-276, 2011.
155. J. H. Fritz, L. Le Bourhis, G. Sellge et al., "Nod1-mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity," Immunity, vol. 26, no. 4, pp. 445-459, 2007.
156. C. C. Allison, T. A. Kufer, E. Kremmer, M. Kaparakis, and R. L. Ferrero, "Helicobacter pylori induces MAPK phosphorylation and AP-1 activation via a NOD1-dependent mechanism," Journal of Immunology, vol. 183, no. 12, pp. 8099-8109, 2009.
157. J. Ferrand and R. L. Ferrero, "Recognition of extracellular bacteria by NLRs and its role in the development of adaptive immunity," Frontiers in Immunology, vol. 4, no. 344, pp. 1-12, 2013.
158. Q. Pan, V. Kravchenko, A. Katz et al., "NF-κB-inducing kinase regulates selected gene expression in the Nod2 signaling pathway," Infection and Immunity, vol. 74, no. 4, pp. 2121-2127, 2006.
159. J.-H. Park, Y.-G. Kim, C. McDonald et al., "RICK/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs," The Journal of Immunology, vol. 178, no. 4, pp. 2380-2386, 2007.
160. J.-H. Park, Y.-G. Kim, M. Shaw et al., "Nod1/RICK and TLR signaling regulate chemokine and antimicrobial innate immune responses in mesothelial cells," The Journal of Immunology, vol. 179, no. 1, pp. 514-521, 2007.
161. K. Geddes, S. Rubino, C. Streutker et al., "Nod1 and Nod2 regulation of inflammation in the Salmonella colitis model," Infection and Immunity, vol. 78, no. 12, pp. 5107-5115, 2010.
162. T. Langefeld, W. Mohamed, R. Ghai, and T. Chakraborty, "Toll-like receptors and NOD-likereceptors: domain architecture and cellular signaling," in Target Pattern Recognition in Innate Immunity, Landes Bioscience and Springer Science, 2009.
163. C. Nembrini, J. Kisielow, A. T. Shamshiev et al., "The kinase-activity of Rip2 determines its stability and consequently Nod1 - and Nod2-mediated immune responses," Journal of Biological Chemistry, vol. 284, no. 29, pp. 19183-19188, 2009.
164. H. T. Le and J. A. Harton, "Pyrin- and CARD-only proteins as regulators of NLR functions," Frontiers in Immunology, vol. 4, article 275, Article ID Article 275, 10 pages, 2013.
165. J. G. Magalhaes, M. T. Sorbara, S. E. Girardin, and D. J. Philpott, "What is new with Nods?" Current Opinion in Immunology, vol. 23, no. 1, pp. 29-34, 2011.
166. M. J. M. Bertrand, K. Doiron, K. Labbé, R. G. Korneluk, P. A. Barker, and M. Saleh, "Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immune signaling by the pattern recognition receptors NOD1 and NOD2," Immunity, vol. 30, no. 6, pp. 789-801, 2009.
167. P. Vandenabeele and M. J. M. Bertrand, "The role of the IAP E3 ubiquitin ligases in regulating pattern-recognition receptor signalling," Nature Reviews Immunology, vol. 12, no. 12, pp. 833-844, 2012.
168. D. Zhang, G. Zhang, M. S. Hayden et al., "A Toll-like receptor that prevents infection by uropathogenic bacteria," Science, vol. 303, no. 5663, pp. 1522-1526, 2004.
169. B. Zurek, M. Proell, R. N. Wagner, R. Schwarzenbacher, and T. A. Kufer, "Mutational analysis of human NOD1 and NOD2 NACHT domains reveals different modes of activation," Innate Immunity, vol. 18, no. 1, pp. 100-111, 2012.
170. A. Uehara, S. Yang, Y. Fujimoto et al., "Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture," Cellular Microbiology, vol. 7, no. 1, pp. 53-61, 2005.
171. A. Uehara and H. Takada, "Synergism between TLRs and NOD1/2 in oral epithelial cells," Journal of Dental Research, vol. 87, no. 7, pp. 682-686, 2008.
172. J. H. Fritz, S. E. Girardin, C. Fitting et al., "Synergistic stimulation of human monocytes and dendritic cells by toll-like receptor 4 and NOD1- and NOD2- activating agonists," European Journal of Immunology, vol. 35, no. 8, pp. 2459-2470, 2005.
173. K. S. Kobayashi, M. Chamaillard, Y. Ogura et al., "Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract," Science, vol. 307, no. 5710, pp. 731-734, 2005.
174. H. Tada, S. Aiba, K. I. Shibata, T. Ohteki, and H. Takada, "Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells," Infection and Immunity, vol. 73, no. 12, pp. 7967-7976, 2005.
175. D. A. van Heel, S. Ghosh, M. Butler et al., "Synergistic enhancement of Toll-like receptor responses by NOD1 activation," European Journal of Immunology, vol. 35, no. 8, pp. 2471-2476, 2005.
176. M. G. Netea, G. Ferwerda, D. J. de Jong et al., "Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release," The Journal of Immunology, vol. 174, no. 10, pp. 6518-6523, 2005.
177. B. C. Mercier, E. Ventre, M.-L. Fogeron et al., "NOD1 cooperates with TLR2 to enhance T cell receptor-mediated activation in CD8 T cells," PLoS ONE, vol. 7, no. 7, Article ID e42170, 2012.
178. H. Schwarz, G. Posselt, P. Wurm, M. Ulbing, A. Duschl, and J. Horejs-Hoeck, "TLR8 and NOD signaling synergistically induce the production of IL-1β and IL-23 in monocyte-derived DCs and enhance the expression of the feedback inhibitor SOCS2," Immunobiology, vol. 218, no. 4, pp. 533-542, 2013.
179. G. Ferwerda, B. J. Kullberg, D. J. de Jong et al., "Mycobacterium paratuberculosis is recognized by Toll-like receptors and NOD2," Journal of Leukocyte Biology, vol. 82, no. 4, pp. 1011-1018, 2007.
180. L. O. Moreira, K. C. El Kasmi, A. M. Smith et al., "The TLR2-MyD88-NOD2-RIPK2 signalling axis regulates a balanced proinflammatory and IL-10-mediated anti-inflammatory cytokine response to Gram-positive cellwalls," Cellular Microbiology, vol. 10, no. 10, pp. 2067-2077, 2008.
181. A. G. Joyee and X. Yang, "Role of toll-like receptors in immune responses to chlamydial infections," Current Pharmaceutical Design, vol. 14, no. 6, pp. 593-600, 2008.
182. W. R. Berrington, K. D. Smith, S. J. Skerrett, and T. R. Hawn, "Nucleotide-binding oligomerization domain containing-like receptor family, caspase recruitment domain (CARD) containing 4 (NLRC4) regulates intrapulmonary replication of aerosolized Legionella pneumophila," BMC Infectious Diseases, vol. 13, no. 1, article 371, 2013.
183. K. A. Archer, F. Ader, K. S. Kobayashi, R. A. Flavell, and C. R. Roy, "Cooperation between multiple microbial pattern recognition systems is important for host protection against the intracellular pathogen Legionella pneumophila," Infection and Immunity, vol. 78, no. 6, pp. 2477-2487, 2010.
184. M. S. Jabir, N. D. Ritchie, D. Li et al., "Caspase-1 cleavage of the TLR adaptor TRIF inhibits autophagy and β-interferon production during Pseudomonas aeruginosa infection," Cell Host and Microbe, vol. 15, no. 2, pp. 214-227, 2014.
185. E. Faure, J.-B. Mear, K. Faure et al., "Pseudomonas aeruginosa type-3 secretion system dampens host defense by exploiting the NLRC4-coupled inflammasome," American Journal of Respiratory andCritical Care Medicine, vol. 189, no. 7, pp. 799-811, 2014.
186. D.-J. Kim, J.-H. Park, L. Franchi, S. Backert, and G. Núñez, "The Cag pathogenicity island and interaction between TLR2/NOD2 and NLRP3 regulate IL-1β production in Helicobacter pylori infected dendritic cells," European Journal of Immunology, vol. 43, no. 10, pp. 2650-2658, 2013.
187. A. I. Tukhvatulin, I. I. Gitlin, D. V. Shcheblyakov et al., "Combined stimulation of toll-like receptor 5 and nod1 strongly potentiates activity of NF-κB, resulting in enhanced innate immune reactions and resistance to Salmonella enterica serovar typhimurium infection," Infection and Immunity, vol. 81, no. 10, pp. 3855-3864, 2013.
188. T. Volz, M. Nega, J. Buschmann et al., "Natural Staphylococcus aureus-derived peptidoglycan fragments activate NOD2 and act as potent costimulators of the innate immune system exclusively in the presence of TLR signals," FASEB Journal, vol. 24, no. 10, pp. 4089-4102, 2010.
189. M. A. Müller-Anstett, P. Müller, T. Albrecht et al., "Staphylococcal peptidoglycan co-localizes with Nod2 and TLR2 and activates innate immune response via both receptors in primary murine keratinocytes," PLoS ONE, vol. 5, no. 10, Article ID e13153, 2010.
190. C. Toma, N. Higa, Y. Koizumi et al., "Pathogenic Vibrio activate NLRP3 inflammasome via cytotoxins and TLR/nucleotide-binding oligomerization domain-mediated NF-κB signaling," The Journal of Immunology, vol. 184, no. 9, pp. 5287-5297, 2010.
191. E. J. Hennessy, A. E. Parker, and L. A. J. O'Neill, "Targeting Toll-like receptors: emerging therapeutics?" Nature Reviews Drug Discovery, vol. 9, no. 4, pp. 293-307, 2010.
192. A. Zhou, S. Li, J. Wu, F. A. Khan, and S. Zhang, "Interplay between microRNAs and host pathogen recognition receptors (PRRs) signaling pathways in response to viral infection," Virus Research, vol. 184, pp. 1-6, 2014.
193. F. J. Sheedy and L. A. J. O'Neill, "Adding fuel to fire:MicroRNAs as a new class of mediators of inflammation," Annals of the Rheumatic Diseases, vol. 67, supplement 3, pp. iii50-iii55, 2008.